{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:34:23Z","timestamp":1761856463013,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.medcli.2020.06.053","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T17:13:22Z","timestamp":1598289202000},"page":"262-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Considerations about the use of antivirals in patients with primary biliary cholangitis and hepatitis B virus early infection"],"prefix":"10.1016","volume":"157","author":[{"given":"Alain R.","family":"Rodr\u00edguez-Orozco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2020.06.053_bib0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jcp.2004.023507","article-title":"Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction","volume":"59","author":"Harada","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.medcli.2020.06.053_bib0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/CS20110065","article-title":"Role of Toll-like receptors in liver health and disease","volume":"121","author":"Broering","year":"2011","journal-title":"Clin Sci"},{"key":"10.1016\/j.medcli.2020.06.053_bib0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1872-034X.2008.00322.x","article-title":"Intractable Liver Diseases Study Group of Japan Fulminant hepatitis and late onset hepatic failure in Japan: summary of 698 patients between 1998 and 2003 analyzed by the Annual Nationwide Survey","volume":"38","author":"Fujiwara","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1016\/j.medcli.2020.06.053_bib0045","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/BF02065528","article-title":"Exacerbation of primary biliary cirrhosis during interferon-\u03b1 2b therapy for chronic active hepatitis C","volume":"40","author":"Maeda","year":"1995","journal-title":"Digest Dis Sci"},{"key":"10.1016\/j.medcli.2020.06.053_bib0050","first-page":"101","article-title":"Can anti-retroviral therapy help patients with primary biliary cirrhosis?","volume":"13","author":"Montano-Loza","year":"2011","journal-title":"Rev Port Cardiol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320305509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320305509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:53:08Z","timestamp":1758419588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775320305509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0025775320305509"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2020.06.053","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations about the use of antivirals in patients with primary biliary cholangitis and hepatitis B virus early infection","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2020.06.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}